Our study lends weight to this argument by suggesting that perturbed lipid metabolism, specifically β–FAO, may be a significant contributor to altered placental function in pregnancies complicated by DM directly as a consequence of hyperglycaemia. The gene discussed is PPIB; the disease is Hyperglycemia.